GNLX GNLX
Company Profile ↓Company Overview
GNLX (GNLX) is a publicly traded company listed on with a market capitalization of $96.82M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.15.
Recent Developments
- Dec 2025 Revenue of $8.00K (+0.0% YoY); net profit $-32.15M.
- Trailing 12 Months Year-on-year growth — revenue +0.0%.
- 5-Year Trend Long-term compounding — revenue CAGR -91.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -91.03% |
| 1 Year: | 0.00% |
Stock Price Performance
| 1 Year: | -28.49% |
| 6 Months: | -7.72% |
| 3 Months: | -9.39% |
| 1 Month: | -15.49% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)33.89 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Revenue declined at -91.0% CAGR over 5 years.
- Trading 69.5% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | 11.00M | 170.00K | - | - | 8.00K | - | - | - | - | - | - |
| Operating Income | -3.46M | -2.80M | 6.34M | -6.46M | -5.39M | -5.31M | -8.12M | -6.89M | -6.94M | -7.82M | -7.79M | -8.19M | -9.17M |
| Net Income | -3.80M | -2.82M | 4.91M | -10.36M | -5.82M | -5.34M | -7.85M | -6.58M | -6.47M | -7.49M | -7.46M | -7.95M | -8.93M |
| Diluted EPS | - | 0.31 | 0.49 | -0.53 | -0.23 | -0.20 | -0.29 | -0.22 | -0.19 | -0.21 | -0.20 | -0.21 | -0.20 |
| R&D Expense | 2.37M | 1.83M | 2.41M | 2.85M | 2.94M | 2.82M | 4.01M | 4.42M | 4.05M | 4.70M | 4.76M | 4.74M | 5.78M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 11.07M | 170.00K | 8.00K | 8.00K |
| Operating Income | -3.01M | -24.16M | -31.70M | -33.21M |
| Net Income | -5.21M | -28.30M | -29.87M | -32.15M |
| Diluted EPS | -0.57 | -1.16 | -0.95 | -0.86 |
| R&D Expense | 9.08M | 12.77M | 19.00M | 19.85M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 5.53M | 27.89M | 34.72M | 19.03M |
| Current Assets | - | 1.89M | 24.20M | 31.55M | 15.13M |
| Cash & Equivalents | - | 397.00K | 9.42M | 8.56M | 5.33M |
| Inventory | - | - | - | - | - |
| Receivables | - | - | - | - | - |
| Total Liabilities | - | 41.31M | 8.42M | 8.44M | 7.48M |
| Current Liabilities | - | 31.63M | 6.55M | 6.90M | 6.22M |
| Long Term Debt | 18.02M | 8.52M | - | - | - |
| Total Debt | - | 26.35M | 2.52M | 1.87M | 1.69M |
| Total Equity | - | -35.78M | 19.47M | 26.27M | 11.54M |
| Shares Outstanding | - | 23.57M | 27.22M | 35.16M | 38.57M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Cash Flow | -3.57M | -20.27M | -21.23M | -25.27M |
| Investing Cash Flow | -49.00K | -14.72M | -8.13M | 12.14M |
| Financing Cash Flow | -478.00K | 44.02M | 28.51M | 9.89M |
| Capital Expenditure | -49.00K | -1.02M | -381.00K | -1.10M |
| Free Cash Flow | -3.62M | -21.30M | -21.61M | -26.37M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | -27.2% | -14,214.7% | -396,200.0% | -415,175.0% |
| Net Margin % | -47.0% | -16,645.3% | -373,362.5% | -401,812.5% |
| ROE % | 14.6% | -145.3% | -113.7% | -278.5% |
| ROCE % | 11.5% | -113.2% | -114.0% | -259.4% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for GNLX
GNLX Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE9kSUVnMTE1T2VweXBfUXFLQjBjaC1zR0NmLWtsUmlJTndNZmt5c2lDUWcxRHROOXZyTE1SZzdiSkJTUWtHdHE5ckxLQ3JaRWxCRVc5cDFwR2Q3SVNnZ2VLSGc1cG1EcUFnLTJvNUFyQW5RaXFNSDlSSnVR?oc=5" target="_blank">GNL…
GNLX|Genelux Corp|Price:2.940|Chg%:-0.110 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1kZkEtSjhKMXN2ekY5TzdIQTdXWGdWcnBOWmJNQWJzdFdTeGRxejlvSV9BcGhLMmhyNDFEMURLWkd3SkM2RUNWZzVMN3FaNGdZODlZUFlta3o1WXdLSWg4XzFfX1ZzSUh1Y0FfSGpn?oc=5" target="_blank">GNLX|Genelux Corp|P…
Genelux (GNLX) 2026 meeting backs director John Smither and auditor - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxNdG5YTUtuTl9BUVRfS0o5MzBDT1RqbFRJanJJOHMwdEozMkdvZjhCQXBmYU8weHhjeG9Ld2x2MWhxRWUwelBMaDd6bk04RTJ1dTRseVNuX2h5aTQ3VUY4WldTYVBvNkg3UGdZMExFVEY2bWtGR1h3Q0FpNUR1X01vSnVPamlrTDkwdVdHaF…
Genelux head of regulatory Ralph Smalling sells $562 in stock - Investing.com
<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxNMHR3MXBVUzRrc3FPT2JxVmZNUi1zUGthcHVDLUdwblNSajQxa1d6UmdCVG5zWFBOMzdyQUtmaG1fMzZocWxMZ2VlUHZhdGhRczhMbjhvX3QtQUE4eHNTVjZBaWhoQWZNRzNyeHQzcHFUallDVVF6Rkp6VFJna21iMC0yM204SlZHR2tySk…
Multiple Insiders Sold Genelux Shares Presenting Weak Signs For Investors - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxNdzlnRmtNZUZTN1p6RERvY1NxRFB3SXAtaU05R2lrNWwxUWJEeUZuV1Z4RTVncmJLTHdURnVTV0R0TXVaMHB5U2lzNGM3dVR3ZjkyT3F5Z2xJRlZqZ1ppUXRPRzR4MjNiLXN5c0JSbXpQdUVxWEQ2WG1sTlNlX2hmZEVQckxrb3ZJd3otX2…
Genelux Corporation (GNLX) Slips Slightly as Stock Tests Key Support Zone - Factor Timing - po-news-eg.net
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxOVnNlVEdYSmFVdWZERElvaXVKM2U3My1sZFFnRU9MNElVLTFLSTVNRnlSMEl1S1Z2WkJxSmhvVEdHdXVmNU0xZ0Y2S2o0dWtYaDU4M185RDctYVgwWkhndnpUX2pVM0FWcVp1ZEViMXMtejhCWV9Kalk3enU5NW0zX1lOUlFma3FUWW81Rj…
GNLX — Frequently Asked Questions
What is the current share price of GNLX?
As of 2026-08-05 17:25 PDT, GNLX trades at $2.51 on NASDAQ/NYSE. Its 52-week range is $2.30 to $8.24.
What is the market capitalisation of GNLX?
GNLX has a market capitalisation of $96.82M on NASDAQ/NYSE.
What is the P/E ratio of GNLX?
GNLX trades at a trailing price-to-earnings (P/E) ratio of -2.92. Its price-to-book (P/B) ratio is 8.39.
Is GNLX a good stock to buy?
This page provides a data-driven analysis of GNLX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.